Medindia

X

Indian Pharma Gets USFDA Approval To Market Tablets To Treat Osteoporosis In The US

by Lakshmi Darshini on  August 31, 2015 at 5:29 PM Drug News   - G J E 4
The US Food and Drug Administration (USFDA) has approved Indian drug firm, Aurobindo Pharma, to manufacture and market its generic version of Eli Lilly's Evista tablets used to treat and prevent osteoporosis in postmenopausal women.
Indian Pharma Gets USFDA Approval To Market Tablets To Treat Osteoporosis In The US
Indian Pharma Gets USFDA Approval To Market Tablets To Treat Osteoporosis In The US
Advertisement

The approval by the USFDA for Raloxifene Hydrochloride tablets is for strength of 60 mg, which is bio and therapeutically equivalent to the reference listed drug product (RLD) Evista, 60 mg of Eli Lilly, the company said in a statement.

Advertisement
The product has an estimated market size of USD 404 million for the 12 months ended June 2015, the company added, citing IMS data. This is the 45th Abbreviated New Drug Application (ANDA) to be approved out of Unit VII formulation facility in Hyderabad for manufacturing oral non-antibiotic products.

Aurobindo now has a total of 210 ANDA approvals, 182 final ones, including 9 from Aurolife Pharma LLC and 28 tentative approvals from US FDA, it added.

Source: PTI
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All